Background Image
Table of Contents Table of Contents
Previous Page  388 / 1498 Next Page
Information
Show Menu
Previous Page 388 / 1498 Next Page
Page Background

RATHL: Impact of Bleomycin

PFS for PET-negative patients (ITT)

HR: 1.11 (0.79 – 1.54), p = 0.53

Johnson et al; Lugano 2015